Salipada, Badria A.

HRN: 23-95-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2023
CEFTRIAXONE 1G (VIAL)
11/08/2023
11/14/2023
IVTT
1 G
Q12
Infected Wound
Waiting Final Action 
11/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/08/2023
11/14/2023
IVTT
600mg
Q6
Infected Wound
Waiting Final Action 
11/08/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/08/2023
11/14/2023
TOPICAL
Apply On Affected Areas
Od
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: